Trilogy Capital’s Synopsys SNPS Stock Holding History

Trilogy Capital’s Portfolio SNPS Stock Details SNPS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-3,001	Closed	-$1.52M	–	341
2024 Q3	$1.52M	Buy	3,001 +1,103	+58%	+$592K	0.08%	158
2024 Q2	$1.13M	Buy	+1,898	New	+$1.07M	0.06%	162

Other funds holding SNPS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Trilogy Capital's SNPS Position: Q4 2024 in Review

Trilogy Capital sold out of Synopsys (SNPS) in Q4 2024, closing a stake of 3,001 shares — an estimated $1.52M sold.

Trilogy Capital first reported a position in SNPS in Q2 2024 and held it in 2 quarters. The position peaked at $1.52M in Q3 2024. 1,292 funds tracked by Wall St. Rank hold SNPS as of Q4 2024.

Trilogy Capital reported no remaining Synopsys position as of Q4 2024 after selling out during the quarter.
Trilogy Capital sold 3,001 Synopsys shares in Q4 2024, an estimated $1.52M.
Trilogy Capital first reported a position in Synopsys in Q2 2024 and held it in 2 quarters.
Trilogy Capital's Synopsys position peaked at $1.52M in Q3 2024.
1,292 funds tracked by Wall St. Rank held Synopsys as of Q4 2024.

Based on Trilogy Capital's 13F filing for Q4 2024, filed 27 Jan 2025.